Borregaard (BRG) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
28 Oct, 2026Business model and strategic direction
Integrated biorefinery converts renewable wood into high-value products, with 94% raw-material utilisation and diversified revenue streams.
2025 segment mix: BioSolutions 56%, BioMaterials 35%, Fine Chemicals 9%; niche leadership and application expertise underpin resilience.
Strategy prioritises specialisation, capacity debottlenecking, geographic scaling, productivity and cost discipline, and sustainability-led demand.
Growth focus is scaling proven high-value products and applications rather than broad expansion, with disciplined capital and operational execution.
2025 sales reached 100 countries; end markets included agriculture 25%, construction 16%, and food and pharma 21%.
Sustainability and innovation
Wood inputs are certified or controlled to PEFC and FSC standards; product benefits include renewable sourcing, favourable GHG footprints and fossil-based alternatives.
Science-based targets call for 42% absolute Scope 1 and 2 GHG reduction by 2030 from 2020, and 90% reduction by 2050 for net zero.
R&D and innovation employed 100 people across Norway, the US and India; 2025 spend was NOK 222m, or 3% of revenue, and innovation rate was 11%.
CDP awarded an A in Climate Change for six consecutive years and an A in Water Security; EcoVadis Gold status ranked in the top 5%.
BioSolutions
Portfolio serves 2,800 customers with 600 products; 2025 sales were distributed across agriculture 45%, construction 15% and other markets 40%.
Lignosulfonates hold a clear global leadership position; specialisation and movement into higher-value applications are identified as key growth levers.
Plant nutrition, crop protection and feed offer growth platforms; strategic priorities include scaling proven positions, moving up the value ladder and expanding in APAC and LATAM.
Wood-based vanillin is positioned against plant- and fossil-based alternatives; estimated 2026 market growth is 4–5% for plant-based vanillin and 2–3% for fossil-based vanillin and ethyl vanillin.
Latest events from Borregaard
- Record Q3 EBITDA of NOK 557m; Q4 faces cost, mix and maintenance headwinds.BRG
Q3 2026 - Sharpened focus on specialization and high-value growth targets 5% annual revenue and 25% EBITDA margin.BRG
CMD 2026 - Specialisation, sustainability, and innovation fuel growth in high-value bio-based markets.BRG
Corporate presentation - Q2 revenues and cash flow rose, but Alginor impairment and higher costs hit profit.BRG
Q2 2026 - Sales volumes steady, but cost inflation and market uncertainty drive focus on cost controls.BRG
Pre-close call - Specialisation, innovation, and sustainability drive growth and strong financial performance.BRG
Company presentation - Specialisation, sustainability, and innovation drive growth and value in advanced biorefinery markets.BRG
Corporate presentation - EBITDA fell 16% year-over-year as cost inflation and weaker BioSolutions weighed on results.BRG
Q1 2026 - Specialization, innovation, and sustainability drive growth, backed by strong financials and investment.BRG
CMD 2024